Zaki Hashem advises Premium Healthcare on 10 acquisitions, restructuring, and EGX move

We are proud to have advised Premium Healthcare Group on the successful completion of a landmark transaction involving its acquisition of 10 companies, a major capital restructuring, and the transfer of its listing to the main market of the Egyptian Exchange.

Premium Healthcare Group acquired the following 10 companies operating in medical diagnostics and healthcare services: Hassab Labs, Cairo Clinical Lab, Ezz Laboratories, Cairo Clinical Labs, Ezz laboratories, Maadi Laboratory Acquisitions Company, Khadamat for Hospital Management, Premium Diagnostics, El Eyada Company, Qimet Al Mashrq Company (KSA), Premium Diagnostics (KSA), and Premium Diagnostics LLC (UAE).

The Company’s capital was increased from EGP 81.48 million to EGP 2.363 billion - a nearly 29-fold increase.

The company successfully transitioned its listing from the Nile Stock Exchange (SMEs Market) to the main market of the Egyptian Exchange (EGX), positioning it for enhanced visibility and growth.

This transaction is the largest of its kind in Egypt and represents the first precedent for many of the legal and procedural elements involved. It also stands as one of the country’s most significant restructurings, combining both cash and in-kind capital increases. New shares were issued to existing shareholders and creditors, reflecting a bold and strategic consolidation in the healthcare sector.

Our legal advisory was led by Helal El Hossary, Partner and Head of Capital Markets & Corporate Procedures, and Yasser Hashem, Managing Partner, with valuable support from our Associates Farida Fayez, Ahmed Adel Ammar, Mohamed Abou El-Enain. Our team drafted all transaction documents, navigated complex regulatory frameworks, and secured multiple layers of approval across authorities - all while coordinating a multi-party acquisition and a capital restructuring process.

We extend our sincere appreciation to the Financial Regulatory Authority FRA, MCDR - Misr for Central Clearing, Depository and Registry, and Egyptian Exchange - EGX for their constructive engagement, professionalism, and support throughout the process. Their commitment to market innovation and regulatory clarity played a vital role in the success of this transaction.

Congratulations to our client Premium Healthcare Group and its team for the vision, resilience, and collaboration extended to make this pioneering transaction a reality. We are honored to have contributed to this transformational milestone.